Overview

Bioavailability of Lesinurad and Intravenous [14C]Lesinurad

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study will assess the absolute bioavailability of a single oral dose of lesinurad and evaluate the pharmacokinetic (PK) parameters of lesinurad and [14C]lesinurad in healthy adult male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Ardea Biosciences, Inc.
Treatments:
Lesinurad